Google has filed a patent for a contact lens system with built-in cameras, which essentially is a miniature version of its wearable Glass computer.
The future of ophthalmology—including academic health centers—will rely much on the ability to adapt to an ever-changing environment, suggests Peter J. McDonnell, MD, of the Wilmer Eye Institute.
Alimera Sciences’ recent resubmission of the new drug application (NDA) for its fluocinolone acetonide intravitreal implant (Iluvien) has been received by the FDA as a complete class 2 response to the agency’s October letter, and a prescription drug user fee act (PDUFA) goal date of Sept. 26 has been established.
Paragon BioTeck has received FDA approval of its phenylephrine hydrochloride ophthalmic solution, USP 2.5% and 10%, to dilate the pupil.
Novartis has appointed Jeff George division head of Alcon, effective May 1.